insights_auto
Nega CYTK tushdi 4,42%?
Batafsil oʻrganishchevron_right
CYTK:NASDAQ
Cytokinetics, Inc.
62,70 US$
arrow_downward
-4,42%(-2,90) 1K
62,70 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 5-okt, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoCYTK tikeri uchun statistika yaratilmoqda...
Ochish
65,60 US$
Yuqori
65,76 US$
Past
62,19 US$
Bozor kapitali
8,72 mlrd
Oʻrtacha hajm
2,03 mln
Hajmi
3,23 mln
52 haftalik eng yuqori
88,31 US$
52 haftalik eng past
54,30 US$
Aksiya boʻyicha daromad
-7,22 US$
Beta
0,41
Muomaladagi aksiyalar
139,02 mln
Xodimlar soni
673
Ochish
65,60 US$
Yuqori
65,76 US$
Past
62,19 US$
Bozor kapitali
8,72 mlrd
Oʻrtacha hajm
2,03 mln
Hajmi
3,23 mln
52 haftalik eng yuqori
88,31 US$
52 haftalik eng past
54,30 US$
Aksiya boʻyicha daromad
-7,22 US$
Beta
0,41
Muomaladagi aksiyalar
139,02 mln
Xodimlar soni
673
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
1 kun oldin
Cytokinetics stock heads into four October heart presentations
Profil
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
Cytokinetics, Inc. haqida
CEORobert I. Blum | Robert I. Blum
Xodimlar soni673
Asos solingan1997
Bosh ofislarSouth San Francisco, Kaliforniya, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytcytokinetics.com